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Continuous processing has been an important topic in the biopharmaceutical industry for the past few years. 
However, as this technology is still at an early stage, continuous processing has remained largely siloed to 
individual steps with little thought towards combining each stage to create a fully continuous process.  
 
This presentation will show a fully integrated continuous process, from production bioreactor to drug substance 
at pilot scale, as well as touch on considerations for manufacturing costs and facility throughput. Specific 
emphasis will be given towards the production perfusion bioreactor, capture using multicolumn chromatography, 
viral inactivation, and buffer exchange. 
